Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.